Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing Crohn's disease.

Autor: Taxonera C, Rodrigo L, Casellas F, Calvet X, Gómez-Camacho F, Ginard D, Castro M, Castro L, Ponce M, Martínez-Montiel P, Ricart E, Gisbert JP, Román AL, Morales JM, Casado MA
Zdroj: Journal of Clinical Gastroenterology; 2009 Nov-Dec, Vol. 43 Issue 10, p950-956, 7p
Databáze: Complementary Index